Michel Lagarde
Senior Vice President, Thermo Fisher Scientific Inc.
Companies
- West Pharmaceutical Services UKBoard member Sep 10, 2026 to now1
- West Pharmaceutical Services UKChief executive officer Sep 10, 2026 to now1
- West Pharmaceutical Services UKPresident Sep 10, 2026 to now1
- Vertex PharmaceuticalsBoard member Oct 10, 2023 to now2
- Thermo Fisher Scientific Inc.Senior Vice President Aug 31, 2017 to now3
- Thermo Fisher Scientific Inc.Chief operating officer Feb 25, 2022 to Mar 2, 20264
- PatheonBoard member Feb 2, 2012 to Nov 20, 20135
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Thermo Fisher Scientific Inc. TMO85,151 shares6$58.7M at $689.70Feb 28, 2026- West Pharmaceutical Services UK WST7,850 shares7$3.0M at $383.02Sep 10, 2026
Vertex Pharmaceuticals VRTX1,132 shares8$565.2K at $499.29Oct 5, 2023
As of each latest filing. The line shows shares held over time.
Recent filings
- Feb 28, 2026Shares withheld for tax 360 shares at $521.11 of Thermo Fisher Scientific Inc.6
- Feb 28, 2026Shares withheld for tax 837 shares at $521.11 of Thermo Fisher Scientific Inc.6
- Feb 25, 2026Granted 2,231 shares of Thermo Fisher Scientific Inc.9
- Dec 4, 2025Sold 22,046 shares at $563.56 of Thermo Fisher Scientific Inc.10
- Dec 4, 2025Exercised options 22,046 shares at $132.66 of Thermo Fisher Scientific Inc.10
- Dec 4, 2025Exercised options 18,637 shares at $105.17 of Thermo Fisher Scientific Inc.10
- Dec 3, 2025Sold 2,521 shares at $584.11 of Thermo Fisher Scientific Inc.11
- Dec 3, 2025Sold 29,479 shares at $583.33 of Thermo Fisher Scientific Inc.11
- Dec 3, 2025Exercised options 68,000 shares at $105.17 of Thermo Fisher Scientific Inc.11
- Dec 2, 2025Sold 30,000 shares at $581.92 of Thermo Fisher Scientific Inc.11
- Dec 2, 2025Exercised options 36,000 shares at $105.17 of Thermo Fisher Scientific Inc.11
- Nov 13, 2025Sold 4,638 shares at $594.42 of Thermo Fisher Scientific Inc.12
- Nov 13, 2025Exercised options 4,638 shares at $253.99 of Thermo Fisher Scientific Inc.12
- Aug 28, 2025Shares withheld for tax 162 shares at $489.74 of Thermo Fisher Scientific Inc.13
- Aug 28, 2025Shares withheld for tax 275 shares at $489.74 of Thermo Fisher Scientific Inc.13
- Aug 28, 2025Shares withheld for tax 262 shares at $489.74 of Thermo Fisher Scientific Inc.13
- Aug 28, 2025Shares withheld for tax 262 shares at $489.74 of Thermo Fisher Scientific Inc.13
- Feb 28, 2025Shares withheld for tax 1,125 shares at $528.96 of Thermo Fisher Scientific Inc.14
- Feb 28, 2025Shares withheld for tax 433 shares at $528.96 of Thermo Fisher Scientific Inc.14
- Feb 19, 2025Granted 7,418 shares of Thermo Fisher Scientific Inc.15
- Feb 19, 2025Granted 2,231 shares of Thermo Fisher Scientific Inc.15
- Aug 28, 2024Shares withheld for tax 165 shares at $613.14 of Thermo Fisher Scientific Inc.16
- Aug 28, 2024Shares withheld for tax 219 shares at $613.14 of Thermo Fisher Scientific Inc.16
- Aug 28, 2024Shares withheld for tax 262 shares at $613.14 of Thermo Fisher Scientific Inc.16
- Aug 23, 2024Shares withheld for tax 504 shares at $606.12 of Thermo Fisher Scientific Inc.17
Trade performance
| Date | Stock | Trade | Value | Return since | Vs S&P since | Vs S&P, 1 year |
|---|---|---|---|---|---|---|
| Dec 4, 2025 | TMO | Sale | $12.4M | +21.1% | −8.3% | |
| Dec 3, 2025 | TMO | Sale | $18.7M | +20.0% | −7.1% | |
| Dec 2, 2025 | TMO | Sale | $17.5M | +20.0% | −6.8% | |
| Nov 13, 2025 | TMO | Sale | $2.8M | +20.1% | −5.2% | |
| May 14, 2024 | TMO | Sale | $11.8M | +17.1% | +30.4% | +44.0% |
| May 27, 2022 | TMO | Sale | $7.4M | +21.7% | +64.2% | +11.3% |
| May 26, 2022 | TMO | Sale | $9.0M | +29.0% | +61.5% | +7.0% |
| May 25, 2022 | TMO | Sale | $2.7M | +30.4% | +63.9% | +6.9% |
| May 24, 2022 | TMO | Sale | $9.4M | +26.9% | +69.0% | +11.3% |
| Mar 1, 2022 | TMO | Sale | $3.3M | +28.3% | +51.2% | −7.4% |
| May 10, 2021 | TMO | Sale | $10.0M | +50.3% | +34.4% | −18.1% |
| May 7, 2021 | TMO | Sale | $16.1M | +48.7% | +34.2% | −16.1% |
| Feb 12, 2021 | TMO | Sale | $3.7M | +37.2% | +59.4% | +1.3% |
| Mar 4, 2020 | TMO | Sale | $3.8M | +113.2% | +33.5% | −14.7% |
| Mar 3, 2020 | TMO | Sale | $3.8M | +124.4% | +32.6% | −18.3% |
Returns are price-only (no dividends), measured from the trade date.
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2SEC EDGARVertex Pharmaceuticals, Board member
- 3
- 4
- 5SEC EDGARPatheon, Board member
- 6
- 7
- 8
- 9SEC EDGARForm 4 filed Feb 27, 2026
- 10SEC EDGARForm 4 filed Dec 5, 2025
- 11SEC EDGARForm 4 filed Dec 4, 2025
- 12SEC EDGARForm 4 filed Nov 14, 2025
- 13SEC EDGARForm 4 filed Sep 2, 2025
- 14SEC EDGARForm 4 filed Mar 4, 2025
- 15SEC EDGARForm 4 filed Feb 21, 2025
- 16SEC EDGARForm 4 filed Aug 29, 2024
- 17SEC EDGARForm 4 filed Aug 27, 2024